scispace - formally typeset
M

Michael Wahl

Researcher at University of California, San Francisco

Publications -  61
Citations -  1197

Michael Wahl is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Photon counting & Meson. The author has an hindex of 15, co-authored 61 publications receiving 1015 citations. Previous affiliations of Michael Wahl include University of Colorado Boulder.

Papers
More filters
Journal ArticleDOI

Temozolomide-associated hypermutation in gliomas.

TL;DR: What is known about the mechanisms and consequences of TMZ-induced hypermutation and outstanding questions regarding its clinical significance are discussed.
Journal ArticleDOI

Measurement of masses and widths of excited charm mesons D2∗ and evidence for broad states

J. M. Link, +98 more
- 22 Apr 2004 - 
TL;DR: Using data from the FOCUS experiment, the D+π− and D0π+ invariant mass distributions are analyzed to find evidence for broad structures over background in both the neutral and charged final state.
Journal ArticleDOI

Variability of homotopic and heterotopic callosal connectivity in partial agenesis of the corpus callosum: a 3T diffusion tensor imaging and Q-ball tractography study.

TL;DR: Individuals with pAgCC demonstrate a remarkable diversity of callosal connectivity, including a number of heterotopic tracts that are absent in healthy subjects, and more tracts and more extensive fibers within tracts are recovered with HARDI than with DTI.
Journal ArticleDOI

Microstructural correlations of white matter tracts in the human brain

TL;DR: The study of these microstructural relationships between white matter pathways might aid research on the genetic basis and on the behavioral effects of axonal connectivity, as well as provide a revealing new perspective with which to investigate neurological and psychiatric disorders.
Journal ArticleDOI

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide

TL;DR: While this study failed to meet the primary endpoint for objective radiographic response, patients with high-risk low-grade glioma receiving adjuvant temozolomide demonstrated a high rate of radiographic stability and favorable survival outcomes while meaningfully delaying radiotherapy.